Regulators Should Rely on Peers’ GMP Audits to Cut Inspection Burden
Duplicate GMP inspections are a major challenge for biopharmaceutical manufacturing companies. The IFMPA, urges regulators to rely on audits carried out by peers to minimize the time drug firms spend not making medicines. The post Regulators Should Rely on Peers’ GMP Audits to Cut Inspection Burden appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Source
Read the full article at Genengnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.